CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Gefitinib

吉非替尼 杂质对照品Gefitinib Impurities

60 个杂质条目60 impurity entries

本页汇总 吉非替尼 的 60 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 60 impurity reference standards of Gefitinib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 吉非替尼(Gefitinib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesSeparation and estimation of process-related impurities of gefitinib by reverse-phase high-performance liquid chromatography
    Journal of chromatographic science · 2014 · Chandrashekara KA et al.  ·  PMID 23897663  ·  DOI
  2. 杂质研究Impurity studiesEffect of gefitinib on N-nitrosamine-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mice
    Lung cancer (Amsterdam, Netherlands) · 2009 · Kishino D et al.  ·  PMID 19152984  ·  DOI
  3. 分析方法Analytical MethodsDevelopment of an Analytical Quality by Design RP-HPLC Method and Its Validation for Estimation of Gefitinib From Bulk, Tablet Dosage Form, and Complex Nanoformulation
    Journal of AOAC International · 2024 · More MP et al.  ·  PMID 38648750  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisAutomated synthesis of [18F]gefitinib on a modular system
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine · 2012 · Läppchen T et al.  ·  PMID 21975107  ·  DOI
  • 合成方法SynthesisSynthesis of gefitinib from methyl 3-hydroxy-4-methoxy-benzoate
    Molecules (Basel, Switzerland) · 2007 · Li MD et al.  ·  PMID 17851420  ·  DOI

吉非替尼 —— 原料药与杂质对照品Gefitinib — drug substance & impurities

共 61 个条目(含原料药本体)61 items incl. the drug substance
Gefitinib structure
原料药 APIAPI
吉非替尼Gefitinib
Gefitinib
CAS No.184475-35-2
Chemical FormulaC22H24ClFN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 1 structure
1
吉非替尼杂质1Gefitinib Impurity 1
Gefitinib Impurity 1
CAS No.847949-49-9
Chemical FormulaC21H22ClFN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 2 structure
2
吉非替尼杂质2Gefitinib Impurity 2
Gefitinib Impurity 2
CAS No.184475-71-6
Chemical FormulaC15H11ClFN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 3 structure
3
吉非替尼杂质3Gefitinib Impurity 3
Gefitinib Impurity 3
CAS No.847949-56-8
Chemical FormulaC20H22ClFN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 4 structure
4
吉非替尼杂质4Gefitinib Impurity 4
Gefitinib Impurity 4
CAS No.847949-50-2
Chemical FormulaC22H25ClN4O4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 5 structure
5
吉非替尼杂质5Gefitinib Impurity 5
Gefitinib Impurity 5
CAS No.1502829-45-9
Chemical FormulaC29H37ClFN5O4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 6 structure
6
吉非替尼杂质6Gefitinib Impurity 6
Gefitinib Impurity 6
CAS No.153437-78-6
Chemical FormulaC16H13ClFN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 7 Monomer structure
7
吉非替尼杂质7 单体Gefitinib Impurity 7 Monomer
Gefitinib Impurity 7 Monomer
CAS No.2089650-13-3
Chemical FormulaC22H24Cl2N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 8 structure
8
吉非替尼杂质8Gefitinib Impurity 8
Gefitinib Impurity 8
CAS No.179688-53-0
Chemical FormulaC11H10N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 9 structure
9
吉非替尼杂质9Gefitinib Impurity 9
Gefitinib Impurity 9
CAS No.13794-72-4
Chemical FormulaC10H10N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 10 structure
10
吉非替尼杂质10Gefitinib Impurity 10
Gefitinib Impurity 10
CAS No.788136-89-0
Chemical FormulaC17H13ClFN3O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 11 structure
11
吉非替尼杂质11Gefitinib Impurity 11
Gefitinib Impurity 11
CAS No.246512-44-7
Chemical FormulaC15H23N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 13 structure
13
吉非替尼杂质13Gefitinib Impurity 13
Gefitinib Impurity 13
CAS No.847949-51-3
Chemical FormulaC22H24ClFN4O4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 14 structure
14
吉非替尼杂质14Gefitinib Impurity 14
Gefitinib Impurity 14
CAS No.184475-50-1
Chemical FormulaC22H24F2N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 16 structure
16
吉非替尼杂质16Gefitinib Impurity 16
Gefitinib Impurity 16
CAS No.1603814-04-5
Chemical FormulaC22H24ClFN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 17 structure
17
吉非替尼杂质17Gefitinib Impurity 17
Gefitinib Impurity 17
CAS No.199327-61-2
Chemical FormulaC16H21N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 18 structure
18
吉非替尼杂质18Gefitinib Impurity 18
Gefitinib Impurity 18
CAS No.1608115-59-8
Chemical FormulaC22H23ClFN3O4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 19 Hydrochloride structure
19
吉非替尼杂质19 盐酸盐Gefitinib Impurity 19 Hydrochloride
Gefitinib Impurity 19 Hydrochloride
CAS No.1561173-24-7
Chemical FormulaC15H21N3O3·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 19 structure
19
吉非替尼杂质19Gefitinib Impurity 19
Gefitinib Impurity 19
CAS No.1803045-02-4
Chemical FormulaC22H24ClFN4O4
Purity>95%现货In stock
10mg25mg50mg100mg
Gefitinib Impurity 19 structure
19
吉非替尼杂质19Gefitinib Impurity 19
Gefitinib Impurity 19
CAS No.675126-27-9
Chemical FormulaC15H21N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 20 structure
20
吉非替尼杂质20Gefitinib Impurity 20
Gefitinib Impurity 20
CAS No.2254241-82-0
Chemical FormulaC22H25FN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 29 structure
29
吉非替尼杂质29Gefitinib Impurity 29
Gefitinib Impurity 29
CAS No.1006378-06-8
Chemical FormulaC15H19N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 32 structure
32
吉非替尼杂质32Gefitinib Impurity 32
Gefitinib Impurity 32
CAS No.861453-16-9
Chemical FormulaC15H21N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 35 structure
35
吉非替尼杂质35Gefitinib Impurity 35
Gefitinib Impurity 35
CAS No.861453-12-5
Chemical FormulaC15H20N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 36 structure
36
吉非替尼杂质36Gefitinib Impurity 36
Gefitinib Impurity 36
CAS No.861453-11-4
Chemical FormulaC15H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 39 structure
39
吉非替尼杂质39Gefitinib Impurity 39
Gefitinib Impurity 39
CAS No.58749-47-6
Chemical FormulaC8H7NO5
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 43 structure
43
吉非替尼杂质43Gefitinib Impurity 43
Gefitinib Impurity 43
CAS No.675126-28-0
Chemical FormulaC15H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 44 structure
44
吉非替尼杂质44Gefitinib Impurity 44
Gefitinib Impurity 44
CAS No.675126-26-8
Chemical FormulaC15H19N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 47 structure
47
吉非替尼杂质47Gefitinib Impurity 47
Gefitinib Impurity 47
CAS No.1208903-74-5
Chemical FormulaC8H8N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 61 structure
61
吉非替尼杂质61Gefitinib Impurity 61
Gefitinib Impurity 61
CAS No.179688-02-9
Chemical FormulaC11H10N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 65 structure
65
吉非替尼杂质65Gefitinib Impurity 65
Gefitinib Impurity 65
CAS No.80547-65-5
Chemical FormulaC8H7NO6
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 81 structure
81
吉非替尼杂质81Gefitinib Impurity 81
Gefitinib Impurity 81
CAS No.7357-67-7
Chemical FormulaC7H14ClNO
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 82 structure
82
吉非替尼杂质82Gefitinib Impurity 82
Gefitinib Impurity 82
CAS No.385784-71-4
Chemical FormulaC15H19N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 83 structure
83
吉非替尼杂质83Gefitinib Impurity 83
Gefitinib Impurity 83
CAS No.2106-04-9
Chemical FormulaC6H5ClFN
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 84 structure
84
吉非替尼杂质84Gefitinib Impurity 84
Gefitinib Impurity 84
CAS No.385784-72-5
Chemical FormulaC15H21N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 91 structure
91
吉非替尼杂质91Gefitinib Impurity 91
Gefitinib Impurity 91
CAS No.621-59-0
Chemical FormulaC8H8O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 92 structure
92
吉非替尼杂质92Gefitinib Impurity 92
Gefitinib Impurity 92
CAS No.350-30-1
Chemical FormulaC6H3ClFNO2
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 94 structure
94
吉非替尼杂质94Gefitinib Impurity 94
Gefitinib Impurity 94
CAS No.1379208-77-1
Chemical FormulaC8H6N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 95 structure
95
吉非替尼杂质95Gefitinib Impurity 95
Gefitinib Impurity 95
CAS No.350-31-2
Chemical FormulaC6H3ClFNO2
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 96 structure
96
吉非替尼杂质96Gefitinib Impurity 96
Gefitinib Impurity 96
CAS No.367-22-6
Chemical FormulaC6H5ClFN
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 100 structure
100
吉非替尼杂质100Gefitinib Impurity 100
Gefitinib Impurity 100
CAS No.385784-68-9
Chemical FormulaC12H15N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 102 structure
102
吉非替尼杂质102Gefitinib Impurity 102
Gefitinib Impurity 102
CAS No.1824074-68-1
Chemical FormulaC10H13NO4
Purity>95%现货In stock
10mg25mg50mg100mg
Gefitinib Impurity 103 structure
103
吉非替尼杂质103Gefitinib Impurity 103
Gefitinib Impurity 103
CAS No.909863-33-8
Chemical FormulaC22H24ClFN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 106 structure
106
吉非替尼杂质106Gefitinib Impurity 106
Gefitinib Impurity 106
CAS No.199327-59-8
Chemical FormulaC16H20ClN3O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 109 structure
109
吉非替尼杂质109Gefitinib Impurity 109
Gefitinib Impurity 109
CAS No.15785-54-3
Chemical FormulaC8H7NO6
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 110 structure
110
吉非替尼杂质110Gefitinib Impurity 110
Gefitinib Impurity 110
CAS No.140647-01-4
Chemical FormulaC8H7NO6
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 111 structure
111
吉非替尼杂质111Gefitinib Impurity 111
Gefitinib Impurity 111
CAS No.63407-32-9
Chemical FormulaC8H9NO4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 112 structure
112
吉非替尼杂质112Gefitinib Impurity 112
Gefitinib Impurity 112
CAS No.162012-72-8
Chemical FormulaC9H8N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 113 structure
113
吉非替尼杂质113Gefitinib Impurity 113
Gefitinib Impurity 113
CAS No.1640351-46-7
Chemical FormulaC15H22N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 115 structure
115
吉非替尼杂质115Gefitinib Impurity 115
Gefitinib Impurity 115
CAS No.205584-69-6
Chemical FormulaC9H6Cl2N2O
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 116 structure
116
吉非替尼杂质116Gefitinib Impurity 116
Gefitinib Impurity 116
CAS No.27050-41-5
Chemical FormulaC14H18Cl2N2
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 120 structure
120
吉非替尼杂质120Gefitinib Impurity 120
Gefitinib Impurity 120
CAS No.50413-44-0
Chemical FormulaC9H11NO4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 121 structure
121
吉非替尼杂质121Gefitinib Impurity 121
Gefitinib Impurity 121
CAS No.690206-97-4
Chemical FormulaC16H13ClFN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 126 structure
126
吉非替尼杂质126Gefitinib Impurity 126
Gefitinib Impurity 126
CAS No.61948-67-2
Chemical FormulaC10H13NO4
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 127 structure
127
吉非替尼杂质127Gefitinib Impurity 127
Gefitinib Impurity 127
CAS No.1292318-17-2
Chemical FormulaC14H20N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 128 structure
128
吉非替尼杂质128Gefitinib Impurity 128
Gefitinib Impurity 128
CAS No.196603-86-8
Chemical FormulaC15H21N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 131 structure
131
吉非替尼杂质131Gefitinib Impurity 131
Gefitinib Impurity 131
CAS No.950596-57-3
Chemical FormulaC18H26N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 136 structure
136
吉非替尼杂质136Gefitinib Impurity 136
Gefitinib Impurity 136
CAS No.847862-65-1
Chemical FormulaC22H24ClFN4O3
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 139 structure
139
吉非替尼杂质139Gefitinib Impurity 139
Gefitinib Impurity 139
CAS No.60702-69-4
Chemical FormulaC7H3ClFN
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 140 structure
140
吉非替尼杂质140Gefitinib Impurity 140
Gefitinib Impurity 140
CAS No.2952661-51-5
Chemical FormulaC31H39N5O7
Purity>95%询价On request
10mg25mg50mg100mg
Gefitinib Impurity 142 structure
142
吉非替尼杂质142Gefitinib Impurity 142
Gefitinib Impurity 142
CAS No.31839-21-1
Chemical FormulaC8H9NO4
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

吉非替尼 —— 研究文献与合成路线Gefitinib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 吉非替尼 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Gefitinib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. PLK1 (polo like kinase 1)-dependent autophagy facilitates gefitinib-induced hepatotoxicity by degrading COX6A1 (cytochrome c oxidase subunit 6A1)
    Luo P, Yan H, Du J, et al. · Autophagy · 2021 · 被引 74cited 74
  2. Dual-Targeting TrxR-EGFR Alkynyl-Au(I) Gefitinib Complex Induces Ferroptosis in Gefitinib-Resistant Lung Cancer via Degradation of GPX4
    Wang L, Ma X, Zhou L, et al. · Journal of medicinal chemistry · 2025 · 被引 13cited 13
  3. A pomalidomide-based gefitinib PROTAC degrader effectively inhibits lung cancer progression in EGFR-TKIs-acquired resistant models by targeting EGFR degradation and ETFA-mediated ATP generation
    Li L, Li Y, Ma X, et al. · Bioorganic chemistry · 2025 · 被引 5cited 5
  4. Farnesyltransferase inhibitor LB42708 disables oncogenic RAS signaling and overcomes gefitinib resistance in NSCLC via FTase α-subunit and RAS degradation
    Luo G, Li D, Peng J, et al. · Cell communication and signaling : CCS · 2026
  5. [A high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of four genotoxic impurities in gefitinib]
    Sun C, Ji Y, Qin K, et al. · Se pu = Chinese journal of chromatography · 2019
  6. Separation and estimation of process-related impurities of gefitinib by reverse-phase high-performance liquid chromatography
    Chandrashekara KA, Udupi A, Reddy CG · Journal of chromatographic science · 2014

合成与制备工艺专利Synthesis & process patents

  1. A PROCESS FOR THE PREPARATION OF GEFITINIB
    AGGARWAL ASHVIN KUMAR, JAIN ANSHUL KUMAR, CHIDAMBARAM VENKATESWARAN SRINIVASAN, WADHWA LALIT · 公开号 WO2010076810WO2010076810 · 2010
  2. PROCESS FOR THE PREPARATION OF GEFITINIB
    RAO DHARMARAJ RAMACHANDRA, KANKAN RAJENDRA NARAYANRAO, PATHI SRINIVAS LAXMINARAYAN · 公开号 WO2008125867WO2008125867 · 2008
  3. PROCESS FOR THE PREPARATION OF GEFITINIB
    RAO DHARMARAJ RAMACHANDRA, KANKAN RAJENDRA NARAYANRAO, PATHI SRINIVAS LAXMINARAYAN · 公开号 EP2155656EP2155656 · 2010
  4. Process for the Preparation of Gefitinib
    RAO DHARMARAJ RAMACHANDRA, KANKAN RAJENDRA NARAYANRAO, PATHI SRINIVAS LAXMINARAYAN · 公开号 US2010137586US2010137586 · 2010
  5. PROCESS FOR THE PREPARATION OF GEFITINIB
    RAO DHARMARAJ RAMACHANDRA, KANKAN RAJENDRA NARAYANRAO, PATHI SRINIVAS LAXMINARAYAN · 公开号 KR20100017101KR20100017101 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

吉非替尼 杂质谱研究要点Gefitinib — impurity profiling notes

下面这些是拿到 吉非替尼 的 61 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 61 impurity entries for Gefitinib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances